COMPOSITIONS COMPRISING DARUNAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FOR USE IN THE TREATMENT OF HIV

COMPOSITIONS COMPRISING DARUNAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FOR USE IN THE TREATMENT OF HIV

The disclosure is directed to methods of treating subjects infected with HIV, once daily, with single unit dosage forms that include darunavir (or a hydrate or solvate thereof), cobicistat, emtricitabine, and a tenofovir prodrug, or salt thereof. La descripción está dirigida a métodos para tratar a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HENRIST Dominiek, NETTLES Richard, MERTENS Roel, OPSOMER Magda, MCCALLISTER Scott, MATHUR Sandeep, PRYZ William, ZIA Vahid, DRIESEN Regina, DE SMEDT Goedele, BOVEN Katia, KAUWENBERGHS Greet
Format: Patent
Sprache:eng ; spa
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The disclosure is directed to methods of treating subjects infected with HIV, once daily, with single unit dosage forms that include darunavir (or a hydrate or solvate thereof), cobicistat, emtricitabine, and a tenofovir prodrug, or salt thereof. La descripción está dirigida a métodos para tratar a sujetos infectados con el VIH, una vez al día, con formas de dosificación unitaria única que incluyen darunavir (o un hidrato o solvato de este), cobicistat, emtricitabina y profármaco de tenofovir o sal de estos.